2020 BRN Discussion, page-19916

My assessment of the SP is that the market does not know how to assess a new tool.
At the risk of a poor example:
Suppose someone invents a screwdriver wrench. The market knows there are individual tools that do the job and the size of those markets. It doesn't know the take-up for new tool. So it waits for some indication.
In our case the market knows that there is a market for "heavy AI", simulating GO, quantum physics in nano-devices.
It knows that Loihi and other technologies are being developed.
The market for BRN shares doesn't know the size of the market for AKIDA use cases.
When Intel made its first chip there were applications in FPGA which could be switched to that chip.

AKIDA's big advantage is low energy at the edge for simple ai. What i mean by that is not playing GO.
It is event based input which matches neural net criteria.
At the risk of another poor example:
Think of a seal recognizing a fish that has come into striking range, not looking at a whole GO board with multiple choices.
The market for BRN shares is waiting for evidence of commercial application.
Be patient.
IMO. DYOR.